Divis Gregory J 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Divis Gregory J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-05+350,000→ 350,000 totalExercise: $4.69Exp: 2032-08-04→ ADSs (350,000 underlying)
Footnotes (2)
- [F1]On August 4, 2022, the Reporting Person was granted an option to purchase 350,000 ADSs, for which vesting was subject to the satisfaction of certain performance criteria. The performance criteria were met on June 5, 2023 (the "First Vesting Date"), resulting in the vesting of 50% of the ADSs underlying such option. The remaining ADSs will vest on the one year anniversary of the First Vesting Date, subject to the Reporting Person's continued service at such time.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.